KA
GILD icon

Kintegral Advisory’s Gilead Sciences GILD Stock Holding History

Kintegral Advisory’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5M Hold
115,097
– – 1.18% 16
2026
Q1 		$16M Sell
115,097
-5,103
-4% -$715K 1.52% 7
2025
Q4 		$14.8M Sell
120,200
-3,290
-3% -$400K 1.25% 12
2025
Q3 		$13.7M Sell
123,490
-552
-0.4% -$62.7K 1.17% 13
2025
Q2 		$13.8M Sell
124,042
-187
-0.2% -$19.9K 1.25% 10
2025
Q1 		$13.9M Sell
124,229
-417
-0.3% -$43K 1.4% 8
2024
Q4 		$11.5M Sell
124,646
-5,807
-4% -$523K 1.09% 16
2024
Q3 		$10.9M Sell
130,453
-1,709
-1% -$130K 1% 17
2024
Q2 		$9.07M Buy
132,162
+51,403
+64% +$3.43M 0.87% 22
2024
Q1 		$5.92M Sell
80,759
-252
-0.3% -$19.4K 0.59% 43
2023
Q4 		$6.56M Sell
81,011
-516
-0.6% -$40.2K 0.73% 35
2023
Q3 		$6.11M Sell
81,527
-48
-0.1% -$3.69K 0.75% 30
2023
Q2 		$6.29M Hold
81,575
– – 0.74% 32
2023
Q1 		$6.77M Sell
81,575
-4,383
-5% -$363K 0.87% 25
2022
Q4 		$7.38M Buy
85,958
+38,996
+83% +$3.09M 0.98% 21
2022
Q3 		$2.9M Hold
46,962
– – 0.4% 69
2022
Q2 		$2.9M Buy
46,962
+994
+2% +$61.5K 0.38% 67
2022
Q1 		$2.73M Buy
45,968
+1,028
+2% +$65.7K 0.3% 83
2021
Q4 		$3.26M Hold
44,940
– – 0.34% 69
2021
Q3 		$3.14M Hold
44,940
– – 0.37% 65
2021
Q2 		$3.1M Hold
44,940
– – 0.37% 64
2021
Q1 		$2.9M Hold
44,940
– – 0.37% 70
2020
Q4 		$2.62M Hold
44,940
– – 0.36% 70
2020
Q3 		$2.84M Sell
44,940
-1,446
-3% -$100K 0.43% 63
2020
Q2 		$3.57M Hold
46,386
– – 0.57% 41
2020
Q1 		$3.47M Buy
46,386
+5,189
+13% +$359K 0.68% 38
2019
Q4 		$2.68M Hold
41,197
– – 0.49% 56
2019
Q3 		$2.61M Hold
41,197
– – 0.52% 48
2019
Q2 		$2.78M Hold
41,197
– – 0.56% 46
2019
Q1 		$2.68M Buy
41,197
+27,349
+197% +$1.82M 0.56% 43
2018
Q4 		$866K Buy
+13,848
New +$968K 0.26% 91

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kintegral Advisory's GILD Position: Q2 2026 in Review

Kintegral Advisory held its Gilead Sciences (GILD) position steady in Q2 2026 at 115,097 shares worth $14.5M. The position accounts for 1.18% of the portfolio, ranked #16.

Kintegral Advisory first reported a position in GILD in Q4 2018 and has held it in 31 quarters since. The position peaked at $16M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Kintegral Advisory held 115,097 shares of Gilead Sciences worth $14.5M as of Q2 2026.
  • Kintegral Advisory left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 1.18% of Kintegral Advisory's portfolio in Q2 2026, its #16 holding.
  • Kintegral Advisory first reported a position in Gilead Sciences in Q4 2018 and has held it in 31 quarters since.
  • Kintegral Advisory's Gilead Sciences position peaked at $16M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Kintegral Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.